Parallax Volatility Advisers, L.P. Tg Therapeutics, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	SELL	$8.36 - $26.5 $581,856 - $1.84 Million	-69,600 Reduced 79.63%	17,800 $148,000
Q2 2023 Aug 14, 2023	BUY	$15.48 - $35.0 $1.35 Million - $3.06 Million	87,400 New	87,400 $2.17 Million
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $3.39 Million - $6.29 Million	155,600 New	155,600 $5.18 Million
Q3 2021 Nov 15, 2021	SELL	$21.78 - $40.45 $3.08 Million - $5.72 Million	-141,500 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $4.6 Million - $6.93 Million	141,500 New	141,500 $5.49 Million
Q4 2018 Feb 14, 2019	SELL	$3.44 - $5.76 $163,400 - $273,600	-47,500 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.15 - $14.0 $244,625 - $665,000	47,500 New	47,500 $266,000

336

87.6M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.